key: cord-1048823-s1maiwy6 authors: Singh, Kunwar; Mittal, Sasha; Gollapudi, Sumanth; Butzmann, Alexandra; Kumar, Jyoti; Ohgami, Robert S. title: A meta‐analysis of SARS‐CoV‐2 patients identifies the combinatorial significance of D‐dimer, C‐reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity date: 2020-10-03 journal: Int J Lab Hematol DOI: 10.1111/ijlh.13354 sha: f513462c37846ce0426dc7a6d8dd561f66033790 doc_id: 1048823 cord_uid: s1maiwy6 BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), known to be the causative agent of COVID‐19, has led to a worldwide pandemic. At presentation, individual clinical laboratory blood values, such as lymphocyte counts or C‐reactive protein (CRP) levels, may be abnormal and associated with disease severity. However, combinatorial interpretation of these laboratory blood values, in the context of COVID‐19, remains a challenge. METHODS: To assess the significance of multiple laboratory blood values in patients with SARS‐CoV‐2 and develop a COVID‐19 predictive equation, we conducted a literature search using PubMed to seek articles that included defined laboratory data points along with clinical disease progression. We identified 9846 papers, selecting primary studies with at least 20 patients for univariate analysis to identify clinical variables predicting nonsevere and severe COVID‐19 cases. Multiple regression analysis was performed on a training set of patient studies to generate severity predictor equations, and subsequently tested on a validation cohort of 151 patients who had a median duration of observation of 14 days. RESULTS: Two COVID‐19 predictive equations were generated: one using four variables (CRP, D‐dimer levels, lymphocyte count, and neutrophil count), and another using three variables (CRP, lymphocyte count, and neutrophil count). In adult and pediatric populations, the predictive equations exhibited high specificity, sensitivity, positive predictive values, and negative predictive values. CONCLUSION: Using the generated equations, the outcomes of COVID‐19 patients can be predicted using commonly obtained clinical laboratory data. These predictive equations may inform future studies evaluating the long‐term follow‐up of COVID‐19 patients. In December 2019, a cluster of atypical pneumonia cases of unknown etiology emerged. This phenomenon was epidemiologically linked to a seafood and wet animal wholesale market in Wuhan, Hubei Province, China. 1 The causative agent was isolated and sequenced from human airway epithelial cells from infected patients and identified as a novel beta coronavirus, named 2019-nCoV. 2 To date, this is the seventh member of the Coronaviridae family that is known to infect humans. The 229E, OC43, NL63, and HKU1 strains usually cause mild illness and are associated with the common cold. 6 Based on published genomic information, the nomenclature for the causative strain was changed to SARS-CoV-2. After identification of this novel virus, the World Health Organization (WHO) named the disease COVID-19. As of July 2020, over 14 million cases have been identified attributing to approximately 600 000 deaths. 7 Due to the overwhelming burden this pandemic has caused on healthcare systems worldwide, there has been a concerted effort to understand the etiology and epidemiology of this disease. To date, there have been multiple articles published to establish clinical features, severity, and mortality. However, it has been difficult to identify diagnostic data that could reliably predict patient outcomes. In both adult and pediatric patients, several studies have suggested that hematological data may be key to determining severity and outcomes in COVID-19. This is particularly attractive in the clinical setting due to rapid availability of these tests in both inpatient settings. 8, 9, 10 Here, we perform a comprehensive meta-analysis of globally reported laboratory data of hospitalized COVID-19 patients to generate COVID-19 severity predictive equations. Clinical severity predictor equations may potentially help physicians more accurately prognosticate outcomes of COVID-19 patients. Articles with information regarding COVID-19 were identified in PubMed in May 2020 using COVID-19, COVID, and SARS-CoV-2 as search keywords yielding 9846 articles. We identified 160 articles that were printed or translated into English, published after December 1, 2019, and containing specific clinical blood laboratory data values ( Figure 1 ). Papers that did not have full CBC data, had <20 patients, and were not original research papers were removed through manual curation. We reviewed these papers for reported F I G U R E 1 Summary of literature search, and articles reviewed and used for analysis significant findings with regard to laboratory data and their univariate significance in outcomes in SARS-CoV-2 patients. This yielded the following possible parameters that were reported significant in outcomes: lymphocyte count, neutrophil count, eosinophil count, D-dimer values, procalcitonin, lactate dehydrogenase, creatinine, albumin, and CRP. We narrowed the relevant variables and papers to 51 remaining papers that had such data and were then evaluated to see whether they contained four variables (D-dimer, neutrophil count, lymphocyte count, and CRP) as these were identified as most significant in univariate analyses in two or more papers in the literature. This resulted in a total of 10 papers, which were used to develop SARS-CoV-2 severity prediction equations. Quantitative analysis, t test, linear regression analysis, and multiple regression analysis Laboratory data variables that were identified as significant in predicting outcomes of COVID-19 patients in two or more papers in literature, which had 20 or more patients, and were from curated studies as described in Materials and Methods were identified and used to generate COVID-19 severity predictive equations (Table S1 ). Ten studies from three different countries (China, Italy, and the United States of America), with annotated patient data, were used to develop COVID-19 severity predictive equations. In these cohorts, severe patients were those that were managed in the intensive care unit (ICU) with symptoms of organ failure or hypoxemic respiratory failure leading to intubation and ventilation, while those who were nonsevere were either patients that did not require hospital admissions or those that only placed on low supplemental oxygen requirements. Using multiple regression analysis, two equations were generated (Table 1) The optimal y value range for predicting outcomes was identified as: y < 0.5 predicted to be nonsevere, y > 0.8 predicted to be severe, and y between 0.5 and 0.8 considered inconclusive. Both COVID-19 severity predictor equations were tested against validation data sets in the adult population (Tables S2 and S3 As pediatric populations have been shown to have altered responses to SARS-CoV-2, 11 we tested both equations that were generated using adult data sets in pediatric cases (Tables S4 and S5 is more precise despite having only three predicator values. Of note, given that there are no published data on comparing these variables, we set arbitrary diagnostic cutoffs, which explains the cases with inconclusive outcomes. COVID-19 initially was thought to only affect the adult population; however, as cases continued to rise throughout the world it was quickly seen that more children were testing positive with contrasting symptoms to that seen in adults. 18 Given that this disease was not recognized in children or adolescents until recently, there is a lack a published data regarding this patient population. We were able to identify 43 reported cases and test our regression equation against these data to see whether age was not a factor in our predictive formula. Both equations had a 100% positive predictive value along with specificity and a high-test yield, but sensitivity was suboptimal. However, the data set we used here was small, and as such, these results require evaluation in a larger data set of pediatric patients. that would provide validation and eliminate these biases. Our severity outcome score could also potentially link patients to ongoing treatment trials. Furthermore, hospital systems could use this as a screening tool to determine potential demand on the healthcare infrastructure (ie, ICU-bed usage, ventilator capacity). In summary, our study defines a novel diagnostic algorithm that when clinically implemented at day 0 of presenting with COVID-19-like symptoms or COVID-19 PCR-confirmed disease, these easily acquirable laboratory data points along with our regression algorithm would impact patient care and potentially reduce mortality in COVID-19 patients. The authors have no significant conflicts of interests to note. K Singh performed data collection, data analysis, and wrote the paper. S Mittal performed data collection, data analysis, and wrote the paper. S Gollapudi and A Butzmann performed data collection and edited the manuscript. J Kumar performed data analysis and wrote the manuscript. RS Ohgami conceived of the idea for this manuscript, performed data analysis, and wrote the paper. Kunwar Singh https://orcid.org/0000-0002-9024-5751 Robert S. Ohgami https://orcid.org/0000-0003-1881-3440 Pneumonia of unknown cause -China A novel coronavirus from patients with pneumonia in China Identification of a novel coronavirus in patients with severe acute respiratory syndrome Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia A novel coronavirus genome identified in a cluster of pneumonia cases-Wuhan Preliminary Phylogenetic Analysis of 11 nCoV2019 Genomes COVID-19) Situation Reports Complex immune dysregulation in COVID-19 patients with severe respiratory failure Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study Eosinophil responses during COVID-19 infections and coronavirus vaccination COVID-19 in children and altered inflammatory responses Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study C-reactive protein levels in the early stage of COVID-19 Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study Remdesivir for the treatment of Covid-19 -preliminary report Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity